A carregar...
Clinical utility of lenalidomide in the treatment of myelodysplastic syndromes
Myelodysplastic syndromes (MDS) represent a heterogeneous group of acquired clonal hematopoietic disorders characterized by peripheral blood cytopenias, paradoxical BM hypercellularity, ineffective hematopoiesis, and increased risk of leukemic transformation. Risk stratification, using different pro...
Na minha lista:
| Publicado no: | J Blood Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4278786/ https://ncbi.nlm.nih.gov/pubmed/25565910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S50482 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|